Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Votubia API Insights Report 2018 -

Research and Markets
Posted on: 19 Dec 18

The "Votubia - API Insight,2018" drug pipelines has been added to's offering.

Votubia - API Insight, 2018 report provides product and API manufacturers' details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to Votubia . The report also highlights the patent details of Votubia .

Scope of the report:

  • A comprehensive product overview including product description, regulatory milestones, safety, pharmacological properties, clinical trials, and product development activities have been elaborated in this report
  • Patent information around Votubia in United States (US) and Europe (EU) has been highlighted
  • API manufacturers for Votubia in United States, Europe, China and India
  • The report contains historical and forecasted sales for Votubia till 2020
  • Enlists the market competition and emerging therapies in the space where Votubia operates

Key Topics Covered:

1. Votubia Overview

2. Votubia Global Sales Assessment

  • Votubia Historical Global Sales
  • Votubia Forecasted Global Sales

3. Product Description

  • Mechanism of Action
  • Pharmacodynamic Properties
  • Pharmacokinetic Properties

4. Product Details by country

5. Patent Information

6. Global API Manufacturers Assessment

  • Active Pharmaceutical Ingredient (API) Manufacturers by Country
  • Active Pharmaceutical Ingredient (API) Manufacturers by Region

For more information about this drug pipelines report visit

View source version on

Business Wire

Last updated on: 19/12/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.